Basilar artery occlusion may be associated with a poor prognosis in the absence of recanalization. Choices in aggressive treatment for this potentially fatal condition vary from intra-arterial or intravenous thrombolysis, endovascular removal, or a combination of the two, with adjunct anti-coagulation therapy. These therapies have proven to be effective in recanalization, whereas conservative management with anti-coagulants alone has had more limited success in the literature. We report a case of basilar artery occlusion managed conservatively with unfractionated heparin, resulting in complete recanalization 3.5 months after symptom onset. Conservative management of basilar artery occlusion with unfractionated heparin was associated with complete recanalization long after symptom onset.
Introduction
Basilar artery occlusion (BAO) has been associated with a high morbidity and mortality, compromising posterior cerebral blood flow to the occipital lobes, medial temporal lobes, the thalami, the cerebellum, and the brain stem. 1 Occlusion in the basilar artery is most often due to atherosclerotic changes or cardioemboli. 2, 3 Clinical recovery is virtually impossible in the absence of recanalization. 3, 4 A medical emergency, BAO calls for aggressive therapies to address clot dissolution, via intraarterial thrombolysis (IAT), intravenous thrombolysis (IVT), and/or endovascular removal. Adjunct therapies include continued heparin and anti-platelet therapies. We report a case in which recanalization on MRA occurs in the absence of aggressive therapy.
Case Report
A 58-year old patient with global left ventricular hypokinesis and wall motion abnormalities presented with acute ataxia, hemiparesis, and decreasing alertness. Initial MRI revealed critically decreased basilar arterial flow likely secondary to a tight stenosis versus complete occlusion of the vessel (Figure 1) , and multiple associated strokes in the posterior circulation distribution (Figure 2 ). Intervention with intra-arterial clot lysis and thrombolytic therapy were initially considered but the patient and family declined an interventional approach, thrombolytic therapy, or angiography. The patient was subsequently admitted to the ICU, kept flat under close observation for several days, received unfractionated IV heparin, and subsequently was administered warfarin over multiple days. Once his course was stable he was discharged to a rehabilitation hospital. The patient had a follow-up MRI/MRA approximately 3.5 months later illustrating no new strokes and complete recanalization of the basilar artery ( Figure 3) . He remains on warfarin, is ambulatory, lives independently, and has only a mild residual hemiparesis and ataxia.
Discussion
BAO can have morbid outcomes, and mortality rate has been reportedly 85-98% even with fibrinolytic, and/or endovascular therapy, if not recanalized.
2,4-7 Morbidities with thrombolysis 
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include extracerebral hemorrhage, asymptomatic or symptomatic acute intracerebral hemorrhage, and neurological damage, most concerning of which is the "locked-in" state 7-11 may occur if these therapies are not considered and bilateral infarction of the brainstem occurs. The outcome of acute BAO depends on the length and location of occlusion, degree of recanalization, and time between onset of symptoms and treatment. 2, 5, 6, [12] [13] [14] [15] [16] Hospital based factors are also important, in that there are a limited number of centers with interventional neuroradiologists capable of endovascular therapy. 17 Various studies have been carried out comparing the efficacy of IAT versus IVT therapy, and/or endovascular management in the setting of BAO, all resulting in remarkable rates of recanalization. The aggressive treatment options are associated with a significant improvement in occlusion; IVT or IAT results in about 40-65% recanalization with 22-24% favorable outcome. 1, 2, 5, 6, 10, 14 The lower improvement in morbidity and the serious risks of these therapies may be grounds for further investigation into conservative management via anti-coagulants potentially resulting in spontaneous recanalization. Our patient's decision to elect medical therapy may be supported by the data of the BASICS study which failed to show any special benefit to IA therapy over IV therapies, with more aggressive therapies entailing greater risks. 18 Early spontaneous recanalization has been reported in the anterior cerebral circulation, whereas late spontaneous recanalization has been documented only in the extracerebral circulation. 19, 20 The MR angiography changes in our patient illustrate that the use of conservative treatment with unfractionated heparin in an acute setting of basilar thrombosis was associated with complete recanalization and restoration of blood flow on MRA by an unknown mechanism within 3.5 months, with a good clinical outcome. There are limited, if any, documented reports of late spontaneous recanalization of the posterior cerebral circulation similar to our case in the English language literature. The incidence, mechanism, and ideal management of this extraordinary finding remain unclear. Reports of this nature call for further investigation into the underlying mechanism of spontaneous recanalization.
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